Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 4/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | BMP2 | P12643 | 2/20 | 0.40 |
| ▸ | VEGFA | P15692 | 2/20 | 0.40 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.40 |
| ▸ | SHH | Q15465 | 2/20 | 0.40 |
| ▸ | SELP | P16109 | 9/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.39 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.39 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.39 |
| ▸ | IFNG | P01579 | 1/20 | 0.38 |
| ▸ | PF4 | P02776 | 1/20 | 0.38 |
| ▸ | CCL2 | P13500 | 1/20 | 0.38 |
| ▸ | BMP6 | P22004 | 1/20 | 0.38 |
| ▸ | CCL11 | P51671 | 1/20 | 0.38 |
| ▸ | WNT3A | P56704 | 1/20 | 0.38 |
| ▸ | SELPLG | Q14242 | 1/20 | 0.38 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.37 |
| ▸ | PTN | P21246 | 1/20 | 0.37 |
| ▸ | MDK | P21741 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16433509 | 0.95 | MAPK1 (0.46) | TLR4MAPK1BMP2VEGFACXCL12 | |
| SCHEMBL19220671 | 0.95 | MAPK1 (0.46) | TLR4MAPK1BMP2VEGFACXCL12 | |
| SCHEMBL19225477 | 0.94 | TLR4 (0.44) | TLR4MAPK1BMP2VEGFACXCL12 | |
| SCHEMBL22617797 | 0.94 | TLR4 (0.44) | TLR4MAPK1BMP2VEGFACXCL12 | |
| SCHEMBL19225429 | 0.94 | TLR4 (0.44) | TLR4MAPK1BMP2VEGFACXCL12 | |
| SCHEMBL19225475 | 0.94 | TLR4 (0.44) | TLR4MAPK1BMP2VEGFACXCL12 | |
| SCHEMBL21565161 | 0.94 | TLR4 (0.44) | TLR4MAPK1BMP2VEGFACXCL12 | |
| SCHEMBL20685511 | 0.94 | TLR4 (0.44) | TLR4MAPK1BMP2VEGFACXCL12 | |
| SCHEMBL19220669 | 0.94 | TLR4 (0.44) | TLR4MAPK1BMP2VEGFACXCL12 | |
| SCHEMBL25853180 | 0.94 | TLR4 (0.44) | TLR4MAPK1BMP2VEGFACXCL12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170223956-A1 | LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH | NOVOZYMES BIOAG A/S (DK) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170223956-A1 | LIPO-CHITOOLIGOSACCHARIDE COMPOSITIONS FOR ENHANCING PLANT GROWTH | CHIT1, LPO, DDOST | TLR4 911/4885MAPK1 4270/4885BMP2 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.